Neutropenia During Cancer Treatment: Infection Risks and Precautions

Neutropenia is a low level of neutrophils, which are important infection-fighting white blood cells. It can occur after chemotherapy, some targeted therapies, radiation to marrow-rich bones, stem cell transplant, or because of the cancer itself.
Key Takeaways
- Neutropenia is a low level of neutrophils, which are important infection-fighting white blood cells.
- It can occur after chemotherapy, some targeted therapies, radiation to marrow-rich bones, stem cell transplant, or because of the cancer itself.
- Fever during neutropenia needs prompt medical assessment, even if there are no other symptoms.
- Hand hygiene, food safety, avoiding sick contacts, and careful skin and mouth care can help reduce infection exposure.
- Doctors may adjust cancer treatment, prescribe antibiotics, or use white blood cell growth factors depending on the patient’s risk.
Neutropenia during cancer treatment means the body has fewer neutrophils, a type of white blood cell that helps fight infection. With careful monitoring, prompt reporting of symptoms, and sensible daily precautions, many patients can reduce infection risk and continue treatment as safely as possible.
Overview
Neutropenia during cancer treatment is a temporary or sometimes longer-lasting decrease in neutrophils, a type of white blood cell made in the bone marrow. Neutrophils are part of the immune system’s first response to bacteria and some fungal infections. When their number is low, the body may have more difficulty controlling an infection early.
Neutropenia is most often discussed in relation to chemotherapy, because many chemotherapy medicines affect fast-growing cells, including cells in the bone marrow that produce blood cells. However, it can also be related to certain targeted therapies, immunotherapies, radiation therapy involving large areas of bone marrow, blood cancers, stem cell transplantation, or previous intensive treatment.
Doctors usually assess neutropenia with a blood test called a complete blood count with differential. A key number is the absolute neutrophil count, or ANC. The lower the ANC and the longer it remains low, the greater the chance that an infection may become serious, which is why cancer teams provide clear instructions about monitoring and when to call.
Symptoms and Warning Signs

Neutropenia itself often does not cause symptoms. A person may feel well even when their neutrophil count is very low. For this reason, scheduled blood tests are important during treatment, especially at the time when blood counts are expected to reach their lowest point, often called the nadir.
The most important warning sign is fever. In a person with neutropenia, fever may be the only sign of infection because the body may not produce typical inflammation, swelling, or pus. Patients should follow the temperature threshold and instructions given by their oncology team, and should not wait for symptoms to worsen before seeking advice.
Other symptoms that should be reported include chills, sweating, new cough, sore throat, shortness of breath, burning during urination, diarrhea, abdominal pain, mouth sores, redness or tenderness around a catheter site, unusual skin changes, or feeling suddenly unwell. Symptoms can be mild at first, so early communication with the care team is the safest approach.
Causes and Risk Factors

Many cancer treatments can lower neutrophil counts by affecting bone marrow activity. Chemotherapy is a common cause, particularly when regimens are known to suppress marrow strongly or when treatments are given close together. Radiation therapy can also contribute if it involves areas where marrow is active, such as the pelvis, spine, ribs, or long bones.
Some cancers increase the risk of neutropenia because they involve the blood or bone marrow directly, such as leukemia, lymphoma, or multiple myeloma. Bone marrow may also be affected by cancer spread, nutritional problems, severe infection, autoimmune conditions, or previous treatments. Age, other chronic illnesses, poor kidney or liver function, and a history of neutropenic complications can influence individual risk.
Risk is not the same for every patient or every treatment cycle. The oncology team considers the treatment plan, blood count trends, overall health, treatment goals, and previous reactions. This helps guide monitoring, preventive medicines when appropriate, and decisions about whether treatment timing or dose needs adjustment.
Diagnosis and Monitoring
Diagnosis is made with a complete blood count and differential, which measures white blood cells and calculates the absolute neutrophil count. Neutropenia is generally classified as mild, moderate, or severe based on the ANC. The classification helps doctors estimate infection risk and decide how closely a patient should be monitored.
If a patient with neutropenia develops fever, the medical team may perform additional tests to look for the source of infection. These may include blood cultures, urine tests, chest imaging, swabs, or examination of intravenous lines and catheter sites. Sometimes no source is found, but treatment may still be started because early care is important.
Monitoring schedules vary according to the type of cancer treatment and the patient’s condition. Some patients need blood tests before each cycle, while others require more frequent checks during periods of expected low counts. Patients should keep their oncology team informed about new medicines, supplements, travel plans, or exposure to infectious illnesses, as these can affect care decisions.
Treatment Options
Treatment depends on how low the neutrophil count is, whether fever or infection is present, and the patient’s overall risk. If neutropenia occurs without fever, the team may recommend observation, repeat blood tests, infection precautions, or changes to the treatment schedule. In some cases, chemotherapy may be delayed or adjusted to allow blood counts to recover.
When fever occurs with neutropenia, doctors usually treat it as an urgent medical situation. Broad-spectrum antibiotics are often started quickly after assessment and appropriate cultures, because bacterial infections can progress faster when neutrophils are low. Some patients may need hospital care, while carefully selected lower-risk patients may be managed with close outpatient follow-up according to medical guidelines.
White blood cell growth factors, such as granulocyte colony-stimulating factors, may be used to reduce the duration or risk of significant neutropenia in certain situations. They are not needed for every patient and are prescribed based on the cancer type, treatment regimen, previous complications, and guideline-based risk assessment. Antiviral or antifungal medicines may also be considered for specific high-risk patients, particularly in hematologic cancers or transplant care.
Prevention and Daily Precautions
Precautions for neutropenia focus on reducing exposure to germs while maintaining normal life as much as possible. Good hand hygiene is one of the most effective steps. Patients and caregivers should wash hands regularly with soap and water or use alcohol-based hand sanitizer, especially before eating, after using the bathroom, after touching pets, and after being in public places.
Food safety is also important. Patients should follow their care team’s advice, which may include eating well-cooked meats, eggs, and seafood; washing fruits and vegetables carefully; avoiding unpasteurized dairy products; and refrigerating food promptly. Drinking safe water and avoiding food that has been stored improperly can reduce gastrointestinal infection risk.
Helpful daily measures may include:
- Avoiding close contact with people who have fever, flu-like symptoms, vomiting, diarrhea, or contagious infections.
- Keeping the mouth clean with gentle oral care and reporting mouth sores early.
- Protecting skin from cuts and cleaning minor injuries promptly.
- Avoiding gardening soil, litter boxes, or standing water unless protective gloves and careful hygiene are used.
- Checking with the oncology team before vaccines, dental procedures, or travel during low-count periods.
Precautions should be balanced and individualized. Most patients do not need to isolate completely unless advised by their doctor. Emotional well-being, nutrition, sleep, and safe physical activity all support overall health during cancer treatment.
When to See a Doctor
Patients receiving cancer treatment should ask their oncology team in advance what temperature is considered a fever and which phone number to call day or night. They should seek medical advice promptly for fever, shaking chills, new breathing symptoms, confusion, severe weakness, persistent diarrhea or vomiting, painful urination, worsening mouth sores, or redness and tenderness around a port or catheter.
It is important not to take fever-reducing medicine, leftover antibiotics, or herbal products to manage symptoms without medical guidance, because these may mask important signs or interact with cancer treatment. Patients should also inform the team if they have been exposed to contagious infections such as influenza, COVID-19, chickenpox, or measles.
For international patients, coordinated care can be especially helpful because blood test timing, urgent contact instructions, and medication plans must be clear. Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and manage neutropenia and infection risks in cancer patients, including those traveling for treatment, with individualized medical planning.
Frequently asked questions
What is neutropenia during cancer treatment?
Neutropenia means the number of neutrophils in the blood is lower than normal. Neutrophils are white blood cells that help protect the body from infections, especially bacterial and some fungal infections. During cancer treatment, neutropenia often happens because treatment temporarily reduces bone marrow production of blood cells.
Why is fever important when neutrophils are low?
Fever may be the first or only sign of infection in a person with neutropenia. Because the immune response can be less visible, infections may not cause typical redness, swelling, or pus. Patients should follow their oncology team’s instructions for when to call or go for urgent assessment.
Can neutropenia be prevented?
Not all neutropenia can be prevented, because it may be an expected effect of effective cancer treatment. However, doctors can estimate risk and may use strategies such as blood count monitoring, treatment schedule adjustments, preventive medicines, or white blood cell growth factors for selected patients. Daily hygiene and food safety also help reduce infection exposure.
Should patients with neutropenia avoid all visitors?
Complete isolation is not usually necessary unless the medical team recommends it. It is sensible to avoid close contact with people who are sick or recently exposed to contagious infections. Visitors should wash their hands well and postpone visits if they have fever, cough, diarrhea, vomiting, or other infectious symptoms.
Are fresh fruits and vegetables safe during neutropenia?
Many patients can eat fresh fruits and vegetables if they are washed thoroughly and handled safely. Some high-risk patients may receive stricter food instructions from their oncology team, especially during stem cell transplant care or severe prolonged neutropenia. Patients should follow the nutrition and food safety advice specific to their treatment plan.
Will cancer treatment stop if neutropenia occurs?
Not always. The oncology team may continue treatment, delay the next cycle, adjust the dose, or add supportive care depending on the severity and the patient’s overall situation. The goal is to treat the cancer effectively while reducing preventable infection risks.
References
- National Comprehensive Cancer Network
- American Society of Clinical Oncology
- European Society for Medical Oncology
- Centers for Disease Control and Prevention
- Infectious Diseases Society of America
This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.
Neutropenia in Turkey — costs, top hospitals & a free quote
JCI-accredited · board-certified surgeons · reply within 24h
Add us as a Preferred Source to see more of our trusted health content across Google Search, AI Overviews and Discover.
Medical Oncology Department
Medical treatment of cancer with chemotherapy, immunotherapy and targeted therapies under a multidisciplinary tumor board.
60 specialists in this unit








